Physician profile
Paolo Andreassi
NPI 1497730162
$2,776.11
in general payments reported to CMS, 2019-2025
26 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $186 · 2021: $149 · 2022: $79.10 · 2023: $530 · 2024: $812 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416 · Travel and Lodging: $427 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.03 |
| Travel and Lodging | $427.12 |
| Education | $162.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $708.01 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Procept Biorobotics Corporation | $475.41 | 2019-2024 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $262.59 | 2023-2025 | Myrisk |
| Astellas Pharma US INC | $219.90 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $153.48 | 2023-2025 | Gemtesa |
| Ferring Pharmaceuticals INC. | $153.07 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $138.57 | 2023-2025 | Botox |
| Neotract INC. | $107.76 | 2020 | |
| 180 Medical, INC. | $81.88 | 2019-2024 | Cure Ultra Catheter, Cure Catheter |
| C. R. Bard, INC. & Subsidiaries | $66.03 | 2025 | Aptra |
| Boston Scientific Corporation | $52.19 | 2019-2025 | Axonics |
| Pfizer INC. | $40.03 | 2019-2020 | |
| Allergan, INC. | $36.93 | 2019-2021 | |
| Ambu INC. | $33.42 | 2025 | |
| Endo Pharmaceuticals INC. | $32.57 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $30.00 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.28 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.33 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.74 | 2023 | Lynparza |
| Axonics, INC. | $19.38 | 2021 | |
| Agiliti Surgical, INC. | $18.26 | 2020 | |
| Srs Medical Systems, INC. | $17.42 | 2023 | Urocuff |
| Davol INC. | $16.47 | 2025 | Arista |
| Angiodynamics, INC. | $16.44 | 2023 | Nanoknife |
| Bard Access Systems, INC. | $15.55 | 2019 | |
| Dornier Medtech America, INC | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paolo Andreassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.